Concentrating Management Resources on R&D and Sales through Outsourced Manufacturing
First written in FY2016. 5 of 7 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2025: 1 of 8 companies on the "Worse" side.
16 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「We conduct research and development and design of blood collection tube preparation systems, specimen testing systems and other products in-house, while outsourcing the manufacturing process to external partner companies. After receiving products from the contract assembly provider in accordance with our incoming inspection standards, we conduct final adjustments in-house and ship products that meet our shipping inspection standards from headquarters. By establishing this structure, we are able to concentrate management resources on research and development, sales and other activities.」
The company continues to operate a production system focused on concentrating management resources, with research and development and design conducted in-house, manufacturing outsourced, and final adjustment and inspection conducted in-house. - FY2022RestatedAnnual report
「We conduct research and development and design of blood collection tube preparation systems, specimen testing systems and other products in-house, while outsourcing the manufacturing process to external partner companies. After receiving products from the contract assembly provider in accordance with our incoming inspection standards, we conduct final adjustments in-house and ship products that meet our shipping inspection standards from headquarters. By establishing this structure, we are able to concentrate management resources on research and development, sales and other activities.」
The company continues to operate a system in which research and development and design are conducted in-house, manufacturing is outsourced, and final adjustment and inspection are conducted in-house. It has also reconfirmed that consumables and healthcare products are blended, manufactured and produced in-house. - FY2021Clarification of in-house operationsAnnual report
「For consumables and other products, the company conducts blending, adjustment, packaging or manufacturing at its head office based on expected order volumes. Healthcare products are researched, developed and produced in-house.」
While continuing to outsource equipment manufacturing, the company explicitly states that consumables and other products and healthcare products are blended, manufactured and produced in-house. - FY2019RestatedAnnual report
「Research and development and design of blood collection tube preparation equipment, specimen testing equipment and other products are conducted in-house, while the manufacturing process is outsourced to external partner companies. After receiving products from the contract assembly company in accordance with the receiving inspection standards, the company conducts final adjustments in-house and ships products meeting the shipping inspection standards from its head office.」
The company continues to operate a production system in which research and development and design are conducted in-house, manufacturing is outsourced, and final adjustment and inspection are conducted in-house. - FY2018RestatedAnnual report
「Research and development and design of blood collection tube preparation equipment, specimen testing equipment and other products are conducted in-house, while the manufacturing process is outsourced to external partner companies. After receiving products from the contract assembly company in accordance with the receiving inspection standards, the company conducts final adjustments in-house and ships products meeting the shipping inspection standards from its head office.」
The company continues to operate a system in which research and development and design are conducted in-house, manufacturing is outsourced, and final adjustment and inspection are conducted in-house. - FY2017RestatedAnnual report
「We conduct research and development and design of blood collection tube preparation systems, specimen testing systems and other products in-house, while outsourcing the manufacturing process to external partner companies. After receiving products from the contract assembly provider in accordance with our incoming inspection standards, we conduct final adjustments in-house and ship products that meet our shipping inspection standards from headquarters. By establishing this structure, we are able to concentrate management resources on research and development, sales and other activities.」
The company continues to operate a production system focused on concentrating management resources, with research and development and design conducted in-house, manufacturing outsourced, and final adjustment and inspection conducted in-house. - FY2016First statedAnnual report
「We conduct research and development and design of blood collection tube preparation systems, specimen testing systems and other systems in-house, while outsourcing the manufacturing process to external partner companies. After receiving products from the contract assembly provider in accordance with our incoming inspection standards, we conduct final adjustments in-house and ship products that meet our shipping inspection standards from headquarters. By establishing this structure, we are able to concentrate management resources on research and development, sales and other activities.」
This describes a division of responsibilities in which design and research and development are conducted in-house, manufacturing is outsourced, and final adjustments and inspections are conducted in-house.